Astrophysics

Does 23andMe's decline show genetic-based medicine has been overhyped?

23andMe's DNA test was once named "invention of the year", but now the company is in dire financial straits. Is this a sign that genetically based medicine's promise has been exaggerated?

SINSIN
Mar 1, 2024 - 16:00
 0  2
Does 23andMe's decline show genetic-based medicine has been overhyped?
23andMe's DNA test was once named "invention of the year", but now the company is in dire financial straits. Is this a sign that genetically based medicine's promise has been exaggerated?
Read More

Tags:

Previous Article

Sinking plankton poo could help store more carbon in the ocean

Next Article

UK spurns European invitation to join ITER nuclear fusion project

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

SIN
SIN ScienceX Information Network (SIN) | ScienceX Innovations

Related Posts

China’s first underwater data centre is being installed

China’s first underwater data centre is being installed

SIN Dec 4, 2023  0  3

The hunt is on to learn why bowel cancer in young people is rising

The hunt is on to learn why bowel cancer in young peopl...

SIN Mar 6, 2024  0  4

Sweeter tomatoes are coming soon thanks to CRISPR gene editing

Sweeter tomatoes are coming soon thanks to CRISPR gene ...

SIN Nov 13, 2024  0  0